Skip to main content
Caplight Logo









Gynion

Gynion

Private
Trumbull, ConnecticutHealthcare & Life Scienceshttps://gynion.com

Last Round

Grant

Sep 1, 2024

Total Funding Raised

$367,472

Company Overview

Gynion operates in Healthcare & Life Sciences and is based in Trumbull, Connecticut. Its latest recorded funding round was a Grant round in September 2024.

Gynion is a medical device company that develops safe, effective, and affordable in-office therapeutic treatments for gynecological conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Gynion Comparables

Compare Gynion with similar companies based on industry and business-model similarity.

Gynion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amplexd Therapeutics
79%
JUNE Medical
77%
Channel Medsystems, Inc.
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Gynion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Oleg Shikhman

CEO and Founder

Founding Team

For institutional investors. Book with your work email.

Gynion Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2024

    $367K grant from the National Cancer Institute

Book a demo to see all signals

For institutional investors. Book with your work email.

Gynion Filings

Explore SEC and related filing metadata, where available.

Gynion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Gynion's valuation, stock price, and market status.

Is Gynion a public or private company?

Gynion is a private company.

What is the current stock price of Gynion?

Gynion is a private company, so its shares have no public market price. Caplight tracks Gynion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Gynion worth (valuation)?

Valuation information for Gynion is not publicly available.

Can I buy Gynion stock?

Gynion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Gynion's last funding round?

Gynion's most recent funding round was Grant on September 1, 2024.

Who are the main investors in Gynion?

Key investors in Gynion include National Cancer Institute, Connecticut Innovations, Bridge Innovations, UConn Innovation Fund.

Will Gynion IPO soon?

No public IPO plans have been announced for Gynion.

How can I track Gynion secondary market activity?

Caplight tracks bids, offers, and trades in Gynion's shares on secondary markets.

Firmographic Details

HeadquartersTrumbull, Connecticut
Employee Range2
Year Founded2016
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?